Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model
Clinical trial NCT03511105 · TERMINATED
Trial details
- NCT number
- NCT03511105
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-25
- Primary completion
- 2018-12-18
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.